Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $148,598 - $186,353
-205 Closed
0 $0
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $121,401 - $162,417
205 New
205 $159 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vinland Capital Management Gestora De Recursos Ltda. Portfolio

Follow Vinland Capital Management Gestora De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vinland Capital Management Gestora De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Vinland Capital Management Gestora De Recursos Ltda. with notifications on news.